How did lomustine become standard of care in recurrent glioblastoma?
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference32 articles.
1. Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling;Nikolova;Biochim Biophys Acta Rev Cancer,2017
2. From old alkylating agents to new minor groove binders;Puyo;Crit Rev Oncol Hematol,2014
3. DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas;Kaina;DNA Repair (Amst),2019
4. Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma;Wick;J Clin Oncol,2010
5. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma;Batchelor;J Clin Oncol,2013
Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Improving glioma drug delivery: A multifaceted approach for glioma drug development;Pharmacological Research;2024-10
2. Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma;Frontiers in Oncology;2024-08-29
3. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma;Cancer Biomarkers;2024-08-27
4. The effects of the combination therapy of chemotherapy drugs on the fluctuations of genes involved in the TLR signaling pathway in glioblastoma multiforme therapy;Biomedicine & Pharmacotherapy;2024-08
5. GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma;Scientific Reports;2024-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3